New device takes on tough Barrett's esophagus cases
NCT ID NCT03364114
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a device called EndoRotor to remove abnormal cells in people with Barrett's esophagus that didn't improve after standard treatments. The device cuts and removes tissue through a scope. Only 15 people took part, and the study was stopped early, so we don't have clear answers on how well it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EndoRotor Mucosal Resection System (a device that cuts and removes tissue through an endoscope)
- What this could lead to
- If successful, this could offer a new way to remove precancerous cells in Barrett's esophagus when standard treatments fail or cause too much pain.
- What could go wrong
- The trial was terminated early with only 15 participants, so results are very limited. It is unclear if the device is better or safer than continued ablation therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT'S ESOPHAGUS WITH DYSPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NHS University College Hospital
London, United Kingdom
-
Sahlgrenska University Hospital
Gothenburg, 413 45, Sweden
-
The Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.